Lv7
4890 积分 2023-02-07 加入
Abstract 7292: HY05350: A trispecific T-cell engager with immune checkpoint inhibitor targeting mesothelin for solid cancer
2小时前
求助中
Structural mechanism of biased activation of T cell receptor by a high-affinity antibody
9天前
已关闭
Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy
17天前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
1个月前
已完结
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals
1个月前
已完结
A coiled-coil masking domain for selective activation of therapeutic antibodies
1个月前
已完结
Structural insight into CD20/CD3-bispecific antibodies by molecular modeling
2个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
2个月前
已完结
The complex patent situation regarding antibody Fc engineering
3个月前
已完结
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
3个月前
已完结
皖公网安备34019202002308
